Skip to content

    Recently Viewed


      A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019

      A year of firsts: 6 ways Johnson & Johnson made history in 2019

      From a first-of-its-kind contact lens that darkens when exposed to bright light to the first donation of 500,000 doses of an Ebola vaccine, here are just some of the ways Johnson & Johnson helped change the trajectory of health for humanity this past year.

      Share Article
      share to

      As we come to the end of the year, it’s natural to want to look back and reflect on all that’s happened over the past 12 months.

      The same is true for us at Johnson & Johnson.
      In our quest to help address unmet health needs around the world, we tackle new challenges—and meet new benchmarks—each and every day, all year long.

      So before we head into 2020, we’re taking a moment to reflect on just some of the milestones that helped us make 2019 a memorable year for helping improve the health and well-being of people across the globe.


      The First Doses of an Ebola Vaccine Regimen Arrived in the Democratic Republic of the Congo and Rwanda

      Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review

      In 2018, Ebola made a resurgence in the Democratic Republic of the Congo (DRC). Today, it’s the world’s second worst Ebola outbreak on record, with over 3,000 confirmed cases and 2,000 deaths. To help protect the people of the DRC and neighboring Rwanda, Johnson & Johnson committed to providing up to 700,000 courses of an investigational Ebola vaccine regimen from the Janssen Pharmaceutical Companies of Johnson & Johnson, developed in collaboration with Bavarian Nordic. The first shipments of the vaccine have arrived in these countries, and over 1,300 people have been vaccinated so far.


      The First (BAND-AID®)RED Campaign Launched to Help Fight HIV/AIDS

      Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review- Lavern Cox year in review

      The new (BAND-AID®)RED campaign brings together several firsts: It’s not only the first collaboration between BAND-AID® Brand adhesive bandages and (RED), but spokesperson Laverne Cox is the first transgender actress to be nominated for three Emmys. Together, the three hope to mobilize all of us to #bandtogether against HIV/AIDS—through the purchase of one box of (BAND-AID®)RED bandages you can help provide a day’s worth of lifesaving medication to someone living with HIV in sub-Saharan Africa.


      The First Chewable Formulation of Johnson & Johnson’s Worm-Fighting Medicine Was Prequalified by the World Health Organization

      Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review- Intestinal Worm Infections year in review

      Intestinal worm infections affect approximately 1.5 billion people worldwide, with children particularly vulnerable to the infection, which can lead to malnutrition, stunted growth and even impaired cognitive development. To help protect kids ages 1 and older against the illness, the Janssen Pharmaceutical Companies of Johnson & Johnson developed a chewable formulation of a medication called mebendazole that, when mixed with a small amount of water, is easier for very young children to swallow. In April, the World Health Organization prequalified the new formulation, which will enable the company to help even more young children at risk of infection.


      The First-of-Its-Kind Contact Lens That Darkens When Exposed to Bright Light Became Available

      Inset- Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review- Acuvue year in review

      Acuvue® Oasys Contact Lenses with Transitions™ Light Intelligent Technology™, which hit the market in 2019, are the first contact lenses to automatically darken when exposed to bright light, darkening in less than a minute and fading back to clear in about 90 seconds when no longer exposed to bright light. They also offer the highest level of UV protection available in contact lenses, filtering blue light, while offering 100% protection against UVB rays.


      The First F.D.A. Approval Was Received for a New Bladder Cancer Treatment

      Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review- Bladder cancer year in review

      It’s the sixth most common cancer, yet treatment options for metastatic bladder cancer remain limited. But there’s now more hope for those in need. In April, the U.S. Food and Drug Administration (FDA) approved a treatment from Janssen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, that may provide promise for some patients living with metastatic urothelial cancer. It’s the first Johnson & Johnson product approved with a companion diagnostic—a test that determines what type of patient would be appropriate for the treatment.


      The First-of-Its-Kind Phase 3 HIV Mosaico Vaccine Trial Launched

      Inset- A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019- Ebola Year in Review- HIV year in review

      The new Mosaico trial will evaluate what’s called a mosaic-based vaccine concept for HIV prevention. The trial is designed with the goal of protecting against a wide range of HIV-1 strains that are responsible for the epidemic around the world, and it’s the first trial to evaluate the Janssen investigational vaccine regimen in men who have sex with men and transgender people ages 18 to 60. It will also be the largest study of the mosaic vaccine to date, with the aim of enrolling 3,800 participants at approximately 56 clinical trial sites across North America, South America and Europe.

      More Ways Johnson & Johnson is Helping Change the World

      Read the 2021 Health for Humanity Report to see how the company is putting health and wellness in reach of people everywhere.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      Health & wellness
      Health worker participating in the Johnson and Johnson single-use device recycling program
      Health & wellness

      3 ways Johnson & Johnson is helping make healthcare more sustainable

      Climate change is intertwined with just about every industry worldwide, including healthcare. Here, a look at how Johnson & Johnson is taking action to help support a healthy planet.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.